{content:title}

Citations Database

Researchers from across the world have utilized Biointron services and products to support their studies. As a comprehensive overview, we have gathered a database of citations that showcase the widespread utilization of Biointron within the scientific community.

Get a 25% off discount when you cite Biointron in your research paper! More info here.

Product/Service
Antibody or Protein Production Catalog Products Antibody Discovery Hybridoma Sequencing
Journal
Acta Pharmaceutica Sinica B Advanced Healthcare Materials Antibodies Antibody Therapeutics Biosensors Cancer Immunology Research Cancer Letters Cancer Research Communications Cancers Carbohydrate Polymers Cell Biomaterials Cell Death and Disease Cell Research Cell Systems EMBO Molecular Medicine eBioMedicine European Journal of Immunology Food and Agricultural Immunology Frontiers in Immunology iScience Immunopharmacology and Immunotoxicology Immunotherapy JCI Insight Journal for ImmunoTherapy of Cancer Journal of Autoimmunity Journal of Bone and Mineral Research Journal of Healthcare Engineering Journal of Immunological Methods Journal of Immunotherapy Journal of Virology MAbs Molecular Cancer Therapeutics Molecular Metabolism Nature Chemical Biology Nature Communications Neurotoxicity Research npj Vaccines Oncogene Research Science Advances Science China Life Sciences Science Immunology Scientific Reports Small Viruses
Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cells

Authors: Yeye Guo, Huaishan Wang, Shujing Liu, Xiaogang Zhang, Xingyue Zhu, Lili Huang, Wenqun Zhong, Lei Guan, Yeqing Chen, Min Xiao, Lingling Ou, Jingbo Yang, Xiang Chen, Alexander C. Huang, Tara Mitchell, Ravi Amaravadi, Giorgos Karakousis, John Miura, Lynn Schuchter, Ahron Flowers, Qiuxian Zheng, Haiwei Mou, Phyllis Gimotty, Meenhard Herlyn, Wei Guo, and Xiaowei Xu

Journal: Science Advances

PubMed ID: 39813334

DOI: https://doi.org/10.1126/sciadv.adp9009

Products & Services: DR5 monoclonal antibodies (tigatuzumab) were manufactured by Biointron

Jan 15, 2025
Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy

Authors: Yu-Jia Chen, Guan-Nan Li, Xian-Jing Li, Lin-Xing Wei, Min-Jie Fu, Zhou-Li Cheng, Zhen Yang, Gui-Qi Zhu, Xu-Dong Wang, Cheng Zhang, Jin-Ye Zhang, Yi-Ping Sun, Hexige Saiyin, Jin Zhang, Wei-Ren Liu, Wen-Wei Zhu, Kun-Liang Guan, Yue Xiong, Yong Yang, Dan Ye, Lei-Lei Chen

Journal: Science Advances

PubMed ID: 37115931

DOI: https://doi.org/10.1126/sciadv.adg0654

Products & Services: Anti-mouse antibody #B176401

Apr 28, 2023

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.